Keyuan Pharmaceutical (301281) In-depth Report: Leading Companies Producing Glitazide and Ropivacaine Hydrochloride in China
東莞證券Jul 18, 2023 18:06
Keyuan Pharmaceutical (301281): IPO Thematic Coverage Report
華金證券Mar 17, 2023 00:00
No Data